Rank | n | AUC version | Indication* | Rating | Description |
Most common test indications overall | |||||
1 | 163 | 2013 | 64 | A | Postrevascularisation with ischaemic equivalent |
2 | 121 | 2013 | 3 | A | Symptomatic with intermediate pretest CAD risk and able to exercise |
3 | 128 | 2009 | 9 | A | Acute chest pain, possible ACS, high TIMI risk, negative troponin |
4 | 76 | 2009 | 8 | A | Acute chest pain, possible ACS, low TIMI risk, negative troponin |
5 | 59 | 2013 | 4 | A | Symptomatic with intermediate pretest CAD risk and unable to exercise |
6 | 45 | 2013 | 58 | A | Non-obstructive CAD on coronary angiography |
7 | 19 | 2013 | 24 | A | Abnormal ECG with intermediate/high CAD risk |
8 | 19 | 2013 | 25 | A | Abnormal exercise ECG test |
9 | 15 | 2013 | 74 | M | Poor/unknown functional capacity, intermediate risk surgery ≥1 risk factor |
10 | 14 | 2013 | 76 | A | Poor/unknown functional capacity, kidney transplant evaluation |
Most common rarely appropriate indications † | |||||
1 | 8 | 2013 | 8 | R | Asymptomatic with intermediate pretest CAD risk and able to exercise |
2 | 3 | 2013 | 71 | R | Moderate or good functional capacity prior to any surgery |
3 | 2 | 2013 | 67 | R | Asymptomatic and <5 years after coronary bypass surgery |
*Indication is the number assigned of the individual AUC clinical scenario described in the table.
†The remainder of rarely appropriate tests were each ordered only once.
ACS, acute coronary syndrome; AUC, Appropriate Use Criteria; CAD, coronary artery disease; TIMI, thrombolysis in myocardial infarction.